Evidence map›Paper›PMID 23507035›Full record

ReviewExperimental neurology2014

Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials.

Elena Giusto, Matteo Donegà, Chiara Cossetti, Stefano Pluchino

Open access · greenAbstract readReview
In one paragraph

Review in Experimental neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Regulation of microglia function by neural stem cells.Frontiers in cellular neuroscience · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. MiR-421 Binds to PINK1 and Enhances Neural Stem Cell Self-RenewalFrontiers in cell and developmental biology · 2021
    Article
  12. Article
  13. Combination of In Situ Lcn2 pRNA-RNAi Nanotherapeutics and iNSC Transplantation Ameliorates Experimental SCI in Mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  14. Review
  15. Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials.International journal of molecular sciences · 2020
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Elena Giusto *Dept of Clinical Neurosciences, John van Geest Centre for Brain Repair, Wellcome Trust/Medical Research Council, Stem Cell Institute, National Institute for Health Research (NIHR), Biomedical Research Centre, University of Cambridge, CB2 0PY, UK.
Matteo Donegà *Dept of Clinical Neurosciences, John van Geest Centre for Brain Repair, Wellcome Trust/Medical Research Council, Stem Cell Institute, National Institute for Health Research (NIHR), Biomedical Research Centre, University of Cambridge, CB2 0PY, UK.
Chiara CossettiDept of Clinical Neurosciences, John van Geest Centre for Brain Repair, Wellcome Trust/Medical Research Council, Stem Cell Institute, National Institute for Health Research (NIHR), Biomedical Research Centre, University of Cambridge, CB2 0PY, UK.
Stefano PluchinoDept of Clinical Neurosciences, John van Geest Centre for Brain Repair, Wellcome Trust/Medical Research Council, Stem Cell Institute, National Institute for Health Research (NIHR), Biomedical Research Centre, University of Cambridge, CB2 0PY, UK.
National Institute for Health Research · GBMedical Research Council · GBWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

European Research Council 260511Wellcome Trust 079249
6 · The paper itself

Abstract

Stem cell technology is a promising branch of regenerative medicine that is aimed at developing new approaches for the treatment of severely debilitating human diseases, including those affecting the central nervous system (CNS). Despite the increasing understanding of the mechanisms governing their biology, the application of stem cell therapeutics remains challenging. The initial idea that stem cell transplants work in vivo via the replacement of endogenous cells lost or damaged owing to disease has been challenged by accumulating evidence of their therapeutic plasticity. This new concept covers the remarkable immune regulatory and tissue trophic effects that transplanted stem cells exert at the level of the neural microenvironment to promote tissue healing via combination of immune modulatory and tissue protective actions, while retaining predominantly undifferentiated features. Among a number of promising candidate stem cell sources, neural stem/precursor cells (NPCs) are under extensive investigation with regard to their therapeutic plasticity after transplantation. The significant impact in vivo of experimental NPC therapies in animal models of inflammatory CNS diseases has raised great expectations that these stem cells, or the manipulation of the mechanisms behind their therapeutic impact, could soon be translated to human studies. This review aims to provide an update on the most recent evidence of therapeutically-relevant neuro-immune interactions following NPC transplants in animal models of multiple sclerosis, cerebral stroke and traumas of the spinal cord, and consideration of the forthcoming challenges related to the early translation of some of these exciting experimental outcomes into clinical medicines.

Indexed as

Stem Cell TransplantationAnimalsCentral Nervous System DiseasesClinical Trials as TopicDisease Models, AnimalHumansMultiple SclerosisNeural Stem CellsClinical trialsImmune modulationNeural stem cellsNeuro-immune interactionsStem cell therapy

Identifiers

PMID23507035
PMCPMC4162671
OpenAlexW2137267666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.